2020

• November 19, 2020: Conversations on Cancer: Lung Cancer: It Can Happen to Anyone. Meeting Information
• September 24, 2020: Conversations on Cancer: Latino Community: Achieving Equity in Cancer Clinical Trials. Meeting Information
• July 17, 2020: FDA-ASCO Public Workshop: 2020 Clinical Outcome Assessments in Cancer Clinical Trials. Meeting Information; #OCEOutcomes20
• June 23, 2020: Conversation on Cancer: LBGTQ plus OCE: A Voice in Clinical Trials. Meeting Information; Webcast
• May 19, 2020: Conversations on Cancer: OCE Salutes the Mosaic of Oncology Nursing.  #OncologyNursingMonth
• February 28, 2020: FDA-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Treatment Trials. Meeting Information; #OCETobaccoUse
• February 20, 2020: Community Engagement with the Community in Mind, Chicago, IL. #OCEProjectCommunity
• February 13, 2020: FDA-AACR Workshop to Examine Under-representation Of African Americans in Multiple Myeloma Clinical Trials. Meeting Information;  #MyelomaDiversity
• February 6, 2020: Conversations on Cancer: OCE Black History Month Presentation, “All Power to the Patient—Achieving Cancer Health Equity.” Webcast; #OCEProjectCommunity.
• February 5, 2020: FDA Oncology Center of Excellence: Envisioning Oncology Product Development for 2025: Meeting information; #OCEProject2025

2019

• October 8, 2019: FDA Public Workshop: Partners in Progress 2019–Cancer Patient Advocates and FDA. Meeting Information; #OCEPIP19
• August 8, 2019: FDA-BCAN Workshop: Endpoints for the Development of Neoadjuvant Systemic Therapy Regimens for Muscle-Invasive Bladder Cancer. Meeting Information; #pCRMIBC2019
• July 19, 2019: FDA-AACR Regulatory Science and Policy Workshop: Real-World Evidence. Meeting Information; #OCEAACRRWE
• July 12, 2019: FDA-ASCO Public Workshop: 2019 Clinical Outcome Assessments in Cancer Clinical Trials. Meeting Information; #OCEOutcomes19
• May 31, 2019: FDA-ASCO Fellows Day Public Workshop: Meeting Information; #FDA_ASCOFellowsDay
• May 16, 2019: FDA-Reagan-Udall Foundation Public Workshop: Project Facilitate & EA Navigator: Working Together to Enable Patient Access to Investigational Oncology Drugs. Meeting Information; #ProjectFacilitate
• May 8-10, 2019: FDA-Duke Public Workshop: Accelerating Anticancer Agent Development and Validation. Meeting Information; #2019AAADV
• April 26, 2019: FDA-ASCO-FOCR Workshop on Development of Tissue-Agnostic, Biomarker-Based Indications. Meeting Information; #FDATissueAgnostic19
• April 17, 2019: FDA-PDS Symposium. Meeting Information
• March 22, 2019: FDA-NBTS Public Workshop: Product Development for Central Nervous System Metastases. Meeting Information; #CNSMetsWorkshop2019
• March 15, 2019: FDA Public Workshop: Childhood Cancer Advocacy Forum. Meeting Information
• March 8, 2019: FDA-ASCO Fellows Day. Meeting Information; #FDA_ASCOFellowsDay 

• December 6, 2018: FDA Public Workshop: Product Development in Hemophilia. Meeting Information; #OCEhemophilia18 
• November 27, 2018: FDA Public Workshop: Partners in Progress 2018 – Cancer Patient Advocates and FDA. Meeting information; #OCEPIP18
• October 29, 2018: FDA Public Workshop: Clinical Trials to Optimize Outcomes in Early Breast Cancer. Meeting Information; #OptimizeEarlyBC
• October 17-18, 2018: FDA-ASH Public Workshop: Sickle Cell Disease Clinical Endpoints. Meeting Information; #OCESickleCell
• July 11, 2018: FDA Public Workshop: Development of Treatments for Localized Prostate Cancer Meeting Information; #FDA FocalTherapyPCa 
• June 22, 2018: 2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop. Meeting Information; #OCEOutcomes 
• June 14, 2018: FDA-AACR-SGO Workshop on Drug Development in Gynecologic Malignancies. Meeting Information; #OCEGynCancers18
• April 20, 2018: OCE Public Meeting on Relevant Molecular Targets in Pediatric Cancers. Meeting Information; #OCEPedsTargets
• March 15, 2018: OCE Listening Session. Meeting Information; #OCEListens2018 ; Webcast Information; Agenda
• March 1-2, 2018: IASLC-FDA Lung Cancer Neoadjuvant Meeting 2018. Meeting Information; #LCN18 
• Feb. 22-23, 2018: FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations. Meeting Information ; #RxRTCombos18 
• Feb. 1, 2018: FDA-ISoP Public Workshop: Model Informed Drug Development for Oncology Products. Meeting Information; #OCEMIDD18 
• Jan. 29, 2018: Weighing the Evidence—Variant Classification and Interpretation in Precision Oncology. Meeting Information; #FDACancerVariant 

2017

• December 1, 2017: Assessment of Cardiovascular Toxicities in Immuno-Oncology Trials. Meeting information; #OCECardioOnc17 
• November 28, 2017: Defining Disease Recurrence and Harmonizing Conduct in Adjuvant Bladder and Kidney Cancer Trials. Meeting information; #OCEGU17 
• November 13, 2017: Partners in Progress: Cancer Patient Advocates and FDA. Save the date: Meeting information
• November 6, 2017: FDA-ASCO Public Workshop: Geriatric Oncology Workshop. Meeting information
• October 10, 2017: FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Part II. Meeting Information 
• July 20, 2017: FDA-AACR Oncology Dose Finding Workshop. Meeting information: FDA; AACR 
• May 3-5, 2017: Accelerating Anticancer Agent Development and Validation Workshop. Meeting information
• April 25, 2017: FDA/C-Path Consortium Second Annual Workshop on Clinical Outcomes Assessments in Cancer Clinical Trials. Meeting information 
• Feb 23, 2017: FDA-ASCO: Hematology and Oncology Fellows Day Workshop. Meeting information